Loading…
MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1
MiR-133b is a muscle-specific microRNA; it has a role in the formation of cardiocytes and the expression of myocardium ion channels by regulating target genes. Many human malignant tumors demonstrate a low expression of miR-133b, as noted in colorectal, lung, esophagus and bladder cancers, but the r...
Saved in:
Published in: | Cancer cell international 2014-07, Vol.14 (1), p.70-70, Article 70 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b589t-ea0a099091933acf0f850bb86f896111255e85a6877fc79011be378d60d7f9623 |
---|---|
cites | cdi_FETCH-LOGICAL-b589t-ea0a099091933acf0f850bb86f896111255e85a6877fc79011be378d60d7f9623 |
container_end_page | 70 |
container_issue | 1 |
container_start_page | 70 |
container_title | Cancer cell international |
container_volume | 14 |
creator | Chen, Xiao-Nan Wang, Ke-Feng Xu, Zhen-Qun Li, Shi-Jie Liu, Qiang Fu, Dong-Hui Wang, Xia Wu, Bin |
description | MiR-133b is a muscle-specific microRNA; it has a role in the formation of cardiocytes and the expression of myocardium ion channels by regulating target genes. Many human malignant tumors demonstrate a low expression of miR-133b, as noted in colorectal, lung, esophagus and bladder cancers, but the role of miR-133b in bladder cancer is unknown.
The expression of miR-133b in clinical bladder cancer specimens and adjacent normal tissues was confirmed by stem-loop RT-PCR. We also analyzed the relationship between miR-133b expression and clinicopathological factors of bladder cancer. Bcl-w and Akt1 protein expression in 41 bladder cancer specimens and adjacent normal tissues was detected by Western blot. After transfection of miR-133b mimics or inhibitor into a T24 human bladder cancer cell line, Bcl-w and Akt1 protein and mRNA expression were examined by Western blot and RT-PCR, respectively. The effect of miR-133b on T24 cell proliferation and apoptosis was measured by CCK-8 tests and flow cytometry, respectively.
The expression of miR-133b in bladder cancer tissues from 41 patients was significantly down-regulated (P |
doi_str_mv | 10.1186/s12935-014-0070-3 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4238049</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3397204091</sourcerecordid><originalsourceid>FETCH-LOGICAL-b589t-ea0a099091933acf0f850bb86f896111255e85a6877fc79011be378d60d7f9623</originalsourceid><addsrcrecordid>eNp1kstq3TAURUVpaR7tB3QSDJ10ouQcy3pNCnknkFAo7bRCtuUbpb6WI8kN-fv45iYhKe3oCM7SZrMkQj4h7CIqsZew1IxTwIoCSKDsDdnESnJaKiHfvjhvkK2UrgFQKgHvyUbJK6y45pvk16X_TpGxuohuMfU2u1TUvW1bF4vGDs1quL4vxhh637losw9DYYe2sGMYc0h-5u-KbOPCZT8sioOmp7cPwP7vjB_Iu872yX18nNvk58nxj8MzevHt9Pxw_4LWXOlMnQULWoNGzZhtOugUh7pWolNaIGLJuVPcCiVl10gNiLVjUrUCWtlpUbJt8nWdO0710rWNG3K0vRmjX9p4Z4L15vVm8FdmEf6YqmQKKj0HHK0Dah_-E_B604SlWfs3s3-z8m_YHPPlsUcMN5NL2Sx9Wgm0gwtTMiiY5JxpJWf081_odZjiMFsyyHmJnGElZgrXVBNDStF1z5UQzOoT_LPEzksZzzeeXp3dA9nIrJI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1552153146</pqid></control><display><type>article</type><title>MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1</title><source>PubMed Central Free</source><source>Publicly Available Content (ProQuest)</source><creator>Chen, Xiao-Nan ; Wang, Ke-Feng ; Xu, Zhen-Qun ; Li, Shi-Jie ; Liu, Qiang ; Fu, Dong-Hui ; Wang, Xia ; Wu, Bin</creator><creatorcontrib>Chen, Xiao-Nan ; Wang, Ke-Feng ; Xu, Zhen-Qun ; Li, Shi-Jie ; Liu, Qiang ; Fu, Dong-Hui ; Wang, Xia ; Wu, Bin</creatorcontrib><description><![CDATA[MiR-133b is a muscle-specific microRNA; it has a role in the formation of cardiocytes and the expression of myocardium ion channels by regulating target genes. Many human malignant tumors demonstrate a low expression of miR-133b, as noted in colorectal, lung, esophagus and bladder cancers, but the role of miR-133b in bladder cancer is unknown.
The expression of miR-133b in clinical bladder cancer specimens and adjacent normal tissues was confirmed by stem-loop RT-PCR. We also analyzed the relationship between miR-133b expression and clinicopathological factors of bladder cancer. Bcl-w and Akt1 protein expression in 41 bladder cancer specimens and adjacent normal tissues was detected by Western blot. After transfection of miR-133b mimics or inhibitor into a T24 human bladder cancer cell line, Bcl-w and Akt1 protein and mRNA expression were examined by Western blot and RT-PCR, respectively. The effect of miR-133b on T24 cell proliferation and apoptosis was measured by CCK-8 tests and flow cytometry, respectively.
The expression of miR-133b in bladder cancer tissues from 41 patients was significantly down-regulated (P < 0.01); low expression of miR-133b was strongly associated with high-grade bladder cancer (P < 0.01). Bcl-w and Akt1 proteins were significantly overexpressed in bladder cancer tissues versus adjacent normal tissues (P < 0.01 for both). The expression of Akt1 and Bcl-w proteins and Akt1 mRNA, in T24 cells was significantly down-regulated or up-regulated after transfection of miR-133b mimics or inhibitor, respectively; however, there was no significant difference in Bcl-w mRNA expression. Transfection of HEK-293 T cells with miR-133b significantly suppressed a luciferase-reporter containing the Bcl-w or Akt 1 3'-untranslated regions. MiR-133b mimics significantly inhibited T24 cell proliferation, as well as increased T24 cell apoptosis (P < 0.05 and P < 0.01, respectively) while the miR-133b inhibitor increased and decreased these, respectively (P < 0.05 for both).
MiR-133b may play a very important role in the proliferation and apoptosis of T24 cells by regulating the expression of Bcl-w and Akt1.]]></description><identifier>ISSN: 1475-2867</identifier><identifier>EISSN: 1475-2867</identifier><identifier>DOI: 10.1186/s12935-014-0070-3</identifier><identifier>PMID: 25414595</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>Apoptosis ; Bladder cancer ; Cell growth ; Flow cytometry ; Gene expression ; Kinases ; Medical research ; MicroRNAs ; Molecular weight ; Primary Research ; Proteins ; Rodents ; Software ; Statistical analysis ; Studies ; Tumors ; Variance analysis</subject><ispartof>Cancer cell international, 2014-07, Vol.14 (1), p.70-70, Article 70</ispartof><rights>2014 Wu et al.; licensee Springer This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</rights><rights>Copyright © 2014 Wu et al.; licensee Springer 2014 Wu et al.; licensee Springer</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b589t-ea0a099091933acf0f850bb86f896111255e85a6877fc79011be378d60d7f9623</citedby><cites>FETCH-LOGICAL-b589t-ea0a099091933acf0f850bb86f896111255e85a6877fc79011be378d60d7f9623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238049/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1552153146?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25414595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Xiao-Nan</creatorcontrib><creatorcontrib>Wang, Ke-Feng</creatorcontrib><creatorcontrib>Xu, Zhen-Qun</creatorcontrib><creatorcontrib>Li, Shi-Jie</creatorcontrib><creatorcontrib>Liu, Qiang</creatorcontrib><creatorcontrib>Fu, Dong-Hui</creatorcontrib><creatorcontrib>Wang, Xia</creatorcontrib><creatorcontrib>Wu, Bin</creatorcontrib><title>MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1</title><title>Cancer cell international</title><addtitle>Cancer Cell Int</addtitle><description><![CDATA[MiR-133b is a muscle-specific microRNA; it has a role in the formation of cardiocytes and the expression of myocardium ion channels by regulating target genes. Many human malignant tumors demonstrate a low expression of miR-133b, as noted in colorectal, lung, esophagus and bladder cancers, but the role of miR-133b in bladder cancer is unknown.
The expression of miR-133b in clinical bladder cancer specimens and adjacent normal tissues was confirmed by stem-loop RT-PCR. We also analyzed the relationship between miR-133b expression and clinicopathological factors of bladder cancer. Bcl-w and Akt1 protein expression in 41 bladder cancer specimens and adjacent normal tissues was detected by Western blot. After transfection of miR-133b mimics or inhibitor into a T24 human bladder cancer cell line, Bcl-w and Akt1 protein and mRNA expression were examined by Western blot and RT-PCR, respectively. The effect of miR-133b on T24 cell proliferation and apoptosis was measured by CCK-8 tests and flow cytometry, respectively.
The expression of miR-133b in bladder cancer tissues from 41 patients was significantly down-regulated (P < 0.01); low expression of miR-133b was strongly associated with high-grade bladder cancer (P < 0.01). Bcl-w and Akt1 proteins were significantly overexpressed in bladder cancer tissues versus adjacent normal tissues (P < 0.01 for both). The expression of Akt1 and Bcl-w proteins and Akt1 mRNA, in T24 cells was significantly down-regulated or up-regulated after transfection of miR-133b mimics or inhibitor, respectively; however, there was no significant difference in Bcl-w mRNA expression. Transfection of HEK-293 T cells with miR-133b significantly suppressed a luciferase-reporter containing the Bcl-w or Akt 1 3'-untranslated regions. MiR-133b mimics significantly inhibited T24 cell proliferation, as well as increased T24 cell apoptosis (P < 0.05 and P < 0.01, respectively) while the miR-133b inhibitor increased and decreased these, respectively (P < 0.05 for both).
MiR-133b may play a very important role in the proliferation and apoptosis of T24 cells by regulating the expression of Bcl-w and Akt1.]]></description><subject>Apoptosis</subject><subject>Bladder cancer</subject><subject>Cell growth</subject><subject>Flow cytometry</subject><subject>Gene expression</subject><subject>Kinases</subject><subject>Medical research</subject><subject>MicroRNAs</subject><subject>Molecular weight</subject><subject>Primary Research</subject><subject>Proteins</subject><subject>Rodents</subject><subject>Software</subject><subject>Statistical analysis</subject><subject>Studies</subject><subject>Tumors</subject><subject>Variance analysis</subject><issn>1475-2867</issn><issn>1475-2867</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp1kstq3TAURUVpaR7tB3QSDJ10ouQcy3pNCnknkFAo7bRCtuUbpb6WI8kN-fv45iYhKe3oCM7SZrMkQj4h7CIqsZew1IxTwIoCSKDsDdnESnJaKiHfvjhvkK2UrgFQKgHvyUbJK6y45pvk16X_TpGxuohuMfU2u1TUvW1bF4vGDs1quL4vxhh637losw9DYYe2sGMYc0h-5u-KbOPCZT8sioOmp7cPwP7vjB_Iu872yX18nNvk58nxj8MzevHt9Pxw_4LWXOlMnQULWoNGzZhtOugUh7pWolNaIGLJuVPcCiVl10gNiLVjUrUCWtlpUbJt8nWdO0710rWNG3K0vRmjX9p4Z4L15vVm8FdmEf6YqmQKKj0HHK0Dah_-E_B604SlWfs3s3-z8m_YHPPlsUcMN5NL2Sx9Wgm0gwtTMiiY5JxpJWf081_odZjiMFsyyHmJnGElZgrXVBNDStF1z5UQzOoT_LPEzksZzzeeXp3dA9nIrJI</recordid><startdate>20140719</startdate><enddate>20140719</enddate><creator>Chen, Xiao-Nan</creator><creator>Wang, Ke-Feng</creator><creator>Xu, Zhen-Qun</creator><creator>Li, Shi-Jie</creator><creator>Liu, Qiang</creator><creator>Fu, Dong-Hui</creator><creator>Wang, Xia</creator><creator>Wu, Bin</creator><general>BioMed Central</general><general>BioMed Central Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TM</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140719</creationdate><title>MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1</title><author>Chen, Xiao-Nan ; Wang, Ke-Feng ; Xu, Zhen-Qun ; Li, Shi-Jie ; Liu, Qiang ; Fu, Dong-Hui ; Wang, Xia ; Wu, Bin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b589t-ea0a099091933acf0f850bb86f896111255e85a6877fc79011be378d60d7f9623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Apoptosis</topic><topic>Bladder cancer</topic><topic>Cell growth</topic><topic>Flow cytometry</topic><topic>Gene expression</topic><topic>Kinases</topic><topic>Medical research</topic><topic>MicroRNAs</topic><topic>Molecular weight</topic><topic>Primary Research</topic><topic>Proteins</topic><topic>Rodents</topic><topic>Software</topic><topic>Statistical analysis</topic><topic>Studies</topic><topic>Tumors</topic><topic>Variance analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Xiao-Nan</creatorcontrib><creatorcontrib>Wang, Ke-Feng</creatorcontrib><creatorcontrib>Xu, Zhen-Qun</creatorcontrib><creatorcontrib>Li, Shi-Jie</creatorcontrib><creatorcontrib>Liu, Qiang</creatorcontrib><creatorcontrib>Fu, Dong-Hui</creatorcontrib><creatorcontrib>Wang, Xia</creatorcontrib><creatorcontrib>Wu, Bin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest - Health & Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer cell international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Xiao-Nan</au><au>Wang, Ke-Feng</au><au>Xu, Zhen-Qun</au><au>Li, Shi-Jie</au><au>Liu, Qiang</au><au>Fu, Dong-Hui</au><au>Wang, Xia</au><au>Wu, Bin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1</atitle><jtitle>Cancer cell international</jtitle><addtitle>Cancer Cell Int</addtitle><date>2014-07-19</date><risdate>2014</risdate><volume>14</volume><issue>1</issue><spage>70</spage><epage>70</epage><pages>70-70</pages><artnum>70</artnum><issn>1475-2867</issn><eissn>1475-2867</eissn><abstract><![CDATA[MiR-133b is a muscle-specific microRNA; it has a role in the formation of cardiocytes and the expression of myocardium ion channels by regulating target genes. Many human malignant tumors demonstrate a low expression of miR-133b, as noted in colorectal, lung, esophagus and bladder cancers, but the role of miR-133b in bladder cancer is unknown.
The expression of miR-133b in clinical bladder cancer specimens and adjacent normal tissues was confirmed by stem-loop RT-PCR. We also analyzed the relationship between miR-133b expression and clinicopathological factors of bladder cancer. Bcl-w and Akt1 protein expression in 41 bladder cancer specimens and adjacent normal tissues was detected by Western blot. After transfection of miR-133b mimics or inhibitor into a T24 human bladder cancer cell line, Bcl-w and Akt1 protein and mRNA expression were examined by Western blot and RT-PCR, respectively. The effect of miR-133b on T24 cell proliferation and apoptosis was measured by CCK-8 tests and flow cytometry, respectively.
The expression of miR-133b in bladder cancer tissues from 41 patients was significantly down-regulated (P < 0.01); low expression of miR-133b was strongly associated with high-grade bladder cancer (P < 0.01). Bcl-w and Akt1 proteins were significantly overexpressed in bladder cancer tissues versus adjacent normal tissues (P < 0.01 for both). The expression of Akt1 and Bcl-w proteins and Akt1 mRNA, in T24 cells was significantly down-regulated or up-regulated after transfection of miR-133b mimics or inhibitor, respectively; however, there was no significant difference in Bcl-w mRNA expression. Transfection of HEK-293 T cells with miR-133b significantly suppressed a luciferase-reporter containing the Bcl-w or Akt 1 3'-untranslated regions. MiR-133b mimics significantly inhibited T24 cell proliferation, as well as increased T24 cell apoptosis (P < 0.05 and P < 0.01, respectively) while the miR-133b inhibitor increased and decreased these, respectively (P < 0.05 for both).
MiR-133b may play a very important role in the proliferation and apoptosis of T24 cells by regulating the expression of Bcl-w and Akt1.]]></abstract><cop>England</cop><pub>BioMed Central</pub><pmid>25414595</pmid><doi>10.1186/s12935-014-0070-3</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1475-2867 |
ispartof | Cancer cell international, 2014-07, Vol.14 (1), p.70-70, Article 70 |
issn | 1475-2867 1475-2867 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4238049 |
source | PubMed Central Free; Publicly Available Content (ProQuest) |
subjects | Apoptosis Bladder cancer Cell growth Flow cytometry Gene expression Kinases Medical research MicroRNAs Molecular weight Primary Research Proteins Rodents Software Statistical analysis Studies Tumors Variance analysis |
title | MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T09%3A27%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MiR-133b%20regulates%20bladder%20cancer%20cell%20proliferation%20and%20apoptosis%20by%20targeting%20Bcl-w%20and%20Akt1&rft.jtitle=Cancer%20cell%20international&rft.au=Chen,%20Xiao-Nan&rft.date=2014-07-19&rft.volume=14&rft.issue=1&rft.spage=70&rft.epage=70&rft.pages=70-70&rft.artnum=70&rft.issn=1475-2867&rft.eissn=1475-2867&rft_id=info:doi/10.1186/s12935-014-0070-3&rft_dat=%3Cproquest_pubme%3E3397204091%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b589t-ea0a099091933acf0f850bb86f896111255e85a6877fc79011be378d60d7f9623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1552153146&rft_id=info:pmid/25414595&rfr_iscdi=true |